Mark Schroeder
About Mark Schroeder
Mark Schroeder is an Associate Scientist at Bristol Myers Squibb, specializing in biopharmaceutical research and development, with expertise in liquid handling robotics, flow cytometry, and primary mammalian cell culture.
Title
Mark Schroeder holds the position of Associate Scientist at Bristol Myers Squibb. Based in Seattle, Washington, he also serves as a Senior Research Associate, contributing to the company's biopharmaceutical research and development initiatives.
Current Role at Bristol Myers Squibb
Mark Schroeder works as an Associate Scientist at Bristol Myers Squibb, focusing on biopharmaceutical research aimed at developing innovative medicines for serious diseases. As part of his role, he contributes to scientific research, collaborates with other scientists, and participates in developing new therapies to improve patient outcomes. His responsibilities may also involve clinical trials and data analysis.
Professional Background
Mark's career includes significant roles in several leading research institutions. He worked at Juno Therapeutics, Inc. as a Senior Research Associate for 9 months in Seattle, Washington, in 2020. Prior to that, he spent two years as a Research Assistant II at Charles River Laboratories in the Greater Chicago Area. He also gained experience as a Research Technician II at Northwestern University for seven months in 2018. Earlier in his career, he served as Researcher I/Graduate Research Associate at Southern Illinois University School of Medicine from 2014 to 2018.
Educational Background
Mark Schroeder holds a Master of Science degree from Southern Illinois University School of Medicine, where he specialized in Medical Microbiology, Immunology, and Cell Biology from 2014 to 2017. He completed his Bachelor of Science in Biology at Benedictine University from 2009 to 2012. Mark also studied General Sciences at the College of Mount Saint Joseph in 2008.
Expertise and Skills
Mark has developed specialized expertise in Liquid Handling Robotics, crucial for high-throughput screening and laboratory automation. He has a strong background in Good Laboratory Practices (GLP) and advanced skills in Flow Cytometry. Mark is proficient in Primary Mammalian Cell Culture, Method Development, and ELISA, techniques essential for various research and drug development processes.